Ho-Sam Ahn

Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

Samuel Chackalamannil, Yuguang Wang, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2008 · 267 citations · Full text

Immunology, Cardiovascular Pharmacology, Pharmacotherapy +21

Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist

Ho-Sam Ahn, Carolyn Foster, George Boykow et al. · Biochemical Pharmacology · 2000 · 139 citations

Thrombopoiesis, Thrombosis, Medicinal Chemistry +10

Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents

Samuel Chackalamannil, Yan Xia, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2005 · 123 citations · Full text

Immunology, Pharmacotherapy, Novel Thrombin Receptor +18

Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity

Ho-Sam Ahn, Ana Bercovici, George Boykow et al. · Journal of Medicinal Chemistry · 1997 · 80 citations · Full text

Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine

Ho-Sam Ahn, Allen Barnett · European Journal of Pharmacology · 1986 · 74 citations

Allergy, Medicine, Anesthetic Mechanism +8